Work

Abstract 2655: DB-1323, a next-generation mesothelin targeting antibody-drug conjugate, demonstrated anti-tumor activity and favorable safety profile in pre-clinical models

Year: 2026

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2026-2655

Authors: Haiqing Hua, Xi Li, Jun Yao, Tao Cheng, Junjie Yang, Xinyue Chen, Sang Pil Lee, Jiyoung Shin, Yunseon Choi, Gisun Baek, Alexandre Joyeux, Jung Chae Lim

Institution: Duality Biotherapeutics, Inc. (China)

Language: English

Topic: Monoclonal and Polyclonal Antibodies Research

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7148646275

Cites:

Cited by:

Related to: